the use of retrogenic mice offers a rapid and flexible approach to t cell receptor (tcr)-transgenic mice. By transducing bone marrow progenitor cells with a retrovirus that encodes a given tcr-a/b subunit, tcr-retrogenic mice can be generated in as few as 4-6 weeks, whereas conventional tcr transgenics can take 6 months or longer. In this updated protocol, we have increased the efficiency of the bone marrow transduction and bone marrow reconstitution compared with our previously published protocol. the main departure from the previous protocol is the implementation of spin transduction with the viral supernatant instead of coculture with the viral producer cell line. the changes in this protocol improve bone marrow viability, increase consistency of the bone marrow transduction and bone marrow engraftment, and they reduce the ratio of bone marrow donor mice to bone marrow recipients. retroviral-mediated stem cell gene transfer 1| Plate viral producer cell lines on 150-mm plates. Allow enough time to passage producer cell lines to obtain two confluent plates (3 × 10 6 producers per plate) per five recipient mice, on the same day bone marrow is collected. All steps throughout the protocol assume five recipient mice per group.  crItIcal step Ensure that producer cells are growing well (i.e., in an exponential growth phase) before injecting 5-fluorouracil (5-FU) into the mice; if the producer cell lines are not healthy or are overgrown, transduction of bone marrow will not occur efficiently.
MaterIals

REAGENTS
2|
Weigh the donor mice (5-12 weeks old) to determine the amount of 5-FU required.
3|
Make a 10 mg ml − 1 working solution of 5-FU in sterile PBS, with each mouse receiving 0.15 mg per gram of body weight. Inject an appropriate volume of 5-FU i.p. using a 27-gauge needle 72 h before collecting the bone marrow. Injection of 5-FU 96 h before collecting the bone marrow results in the recovery of slightly lower bone marrow cell numbers, but it allows similar transduction efficiency and reconstitution compared to 72 h. Injection of 5-FU 48 h before collecting the bone marrow results in the recovery of higher cell numbers, but it yields a similar cell number recovery by the end of transduction protocol compared to 72 h, and thus suggests incomplete apoptosis of rapidly dividing cells of the hematopoietic lineage in the bone marrow before bone marrow isolation. standard bone marrow extraction procedure 4| Cut out the femur and tibia and remove all surrounding tissue using scissors, forceps and paper towels to obtain clean bones. Keep the bones hydrated in HBSS + 5% (vol/vol) FBS. ! cautIon All further steps should be carried out in a biological safety cabinet to prevent contamination of bone marrow.
5|
Cut both ends off each bone, and flush the bones by inserting a 10-ml syringe containing HBSS + 5% (vol/vol) FBS with a 25-gauge needle into the end of the bone. Flush it into a 70-µm strainer resting in a 50-ml tube until the red plug of the bone marrow is removed. Repeat this until all of the bone marrow is released from the bones. By using a plunger from a 1-ml syringe, work the cells through the 70-µm strainer. Rinse the strainer with 10 ml of HBSS + 5% (vol/vol) FBS to ensure that all bone marrow cells are filtered into the 50-ml tube.  crItIcal step Processing of bone marrow and all subsequent steps should be kept as sterile as possible.
6|
Centrifuge the cells at 300g for 10 min at 4 °C, and then decant the supernatant and resuspend the cells in Gey's solution (or comparable red cell lysis buffer). After 3 min of incubation at room temperature (21 °C), quench the Gey's solution with 10 ml of 20% (vol/vol) C-DMEM. Spin the cells at 300g for 10 min at 4 °C, and then aspirate and resuspend them in 20% (vol/vol) C-DMEM to count the cells with a Neubauer counting chamber. General yield should be ~2-3 × 10 7 per B6 Rag1 − / − mouse; however, the yield can vary among different strains (for instance, we recover approximately half as many cells from NOD/SCID mice).  crItIcal step The removal of red blood cells improves transduction efficiency.
7|
Plate the bone marrow cells at a density of 4 × 10 7 cells per 150-mm plate in 30 ml of 20% (vol/vol) C-DMEM supplemented with IL-3 (20 ng ml − 1 ), IL-6 (50 ng ml − 1 ) and SCF (50 ng ml − 1 ) for 24 h in a 37 °C incubator.  crItIcal step The producer cells must be plated on the same day as the bone marrow cells, with both sets of cells being incubated for the same 24-h period.
8| Plate 3 × 10 6 producer cells per plate, with two plates per five recipient mice. Incubate the cells in 18 ml of 20% (vol/vol) C-DMEM for 24 h at 37 °C. ? trouBlesHootInG 9| After 24 h, harvest the retroviral supernatant from the producer cell plates (set up in Step 8) and filter it using a 10-ml syringe and a 0.45-µm filter. Replace the removed retroviral supernatant with 18 ml of fresh 20% (vol/vol) C-DMEM. Supplement the filtered retroviral supernatant with IL-3 (20 ng ml − 1 ), IL-6 (50 ng ml − 1 ), SCF (50 ng ml − 1 ) and polybrene (6 µg ml − 1 ).  crItIcal step Always use freshly thawed cytokines. This can be achieved by first reconstituting the cytokines, and then immediately dividing them into aliquots and freezing the new cytokines to be thawed for later use. We do not suggest using cytokines that have been frozen and thawed more than once or kept at 4 °C for more than 2 weeks. ? trouBlesHootInG 10| After the retroviral supernatant is prepared as in Step 9, harvest the bone marrow cells from the Step 7 plates by decanting the medium into sterile 50-ml tubes, and then washing and scraping the plates with a cell scraper and 10 ml of 20% (vol/vol) C-DMEM. Ensure that the entire surface of the plate has been scraped, decant 20% (vol/vol) C-DMEM into the same 50-ml tubes, and then wash the plates with 5 ml of 20% (vol/vol) C-DMEM to recover the remaining cells. Centrifuge the cells at 300g for 10 min at 4 °C, decant the supernatant and resuspend ~4 × 10 7 cells per ml in 20% (vol/vol) C-DMEM. Add 0.75-1.0 × 10 6 bone marrow cells per 1 ml of the retroviral supernatant containing cytokines and polybrene.
11| Plate the retroviral supernatant/bone marrow mixture at a volume of 3 ml per well of a six-well tissue culture plate. Wrap the plates in plastic wrap to minimize gas exchange.
12|
Spin the wrapped six-well plates at 1,000g (2,500 r.p.m.) for 90 min at 37 °C, and then immediately place the plates in a 37 °C incubator for 24 h. ? trouBlesHootInG 13| After 24 h, repeat Step 9. Filter the retroviral supernatant using a 10-ml syringe and a 0.45-µm filter. Supplement the filtered retroviral supernatant with IL-3 (20 ng ml −1 ), IL-6 (50 ng ml −1 ), SCF (50 ng ml −1 ) and polybrene (6 µg ml −1 ). If you desire, re-plate the viral producer cell line in fresh 20% (vol/vol) C-DMEM in order to use it for a third spin transduction after 24 h. At this point, viral producer cell lines will be confluent and will have to be split again into 3 × 10 6 cells per 150-mm plate in 18 ml of 20% (vol/vol) C-DMEM.
14|
Next, carefully remove and collect the top 2 ml of the supernatant from each well of the six-well plate containing the bone marrow cells. Briefly spin this supernatant down to collect any cells. Resuspend the cells with the freshly filtered retroviral supernatant from Step 13 and transfer it back to the six-well plates containing the remaining bone marrow.
15| Repeat
Step 12. If desired, repeat Steps 13-15 for a third day of spin transduction. This third spin may not be necessary, as we have observed only minimal increase in transduction efficiency after the third spin.
16|
After 24 h, carefully remove and collect the top 2 ml of the supernatant from each well of the six-well plate containing the bone marrow cells. Spin this supernatant down to collect any cells. Decant the supernatant and resuspend the cells with fresh 20% (vol/vol) C-DMEM supplemented with final concentrations of IL-3 (20 ng ml − 1 ), IL-6 (50 ng ml − 1 ) and SCF (50 ng ml −1 ). Transfer the medium containing cytokines and bone marrow back to the six-well plates. Place the six-well plates directly into a 37 °C incubator for 24 h.
17|
After 24 h, collect the bone marrow cells from the six-well plates and centrifuge the cells at 300g for 10 min at 4 °C and decant the supernatant. For the reconstitution of five mice, resuspend the bone marrow in 1 ml of PBS + 0.5% (vol/vol) FBS supplemented with 20 units per ml of heparin per group; this will allow injection of 0.2 ml per mouse.
18| Take a 10-µl sample and count the cells using a Neubauer counting chamber. The yield should be sufficient to transfer at least 4 × 10 6 cells per recipient mouse. We routinely inject five mice per two plates of bone marrow cells. If the yield is substantially lower, more donor mice should be used until this number can be obtained. Take another 10-µl sample for analysis by flow cytometry for GFP + cells. Generally, the percentage of GFP + cells is between 25% and 70%, depending on the construct and retroviral titer. Lower numbers of bone marrow cells may be sufficient to reconstitute mice, depending on the overall transduction efficiency of the progenitor population. Transduction efficiency below 25% may hamper successful reconstitution.
19|
Irradiate mice the day before injection (we use the following: Rag1 − / − mice, 500 rads; C57BL/6 mice, 900 rads; NOD/SCID mice, 300 rads).  crItIcal step If mice are not in a specific pathogen-free or Helicobacter-free facility, they should be placed on Sulfatrim water before irradiation and injection, as well as for the duration of the experiment. Optimal irradiation dose may have to be determined empirically.
20| For injection, load the cells from
Step 18 into 1-ml syringes using blunt needles immediately before injection. Inject the recipient mice using 27-gauge needles. Heat the mice under a heating lamp and inject 0.2 ml of bone marrow per mouse intravenously.
21|
Monitor the mice weekly to ensure that they remain healthy after the irradiation.
22|
After 5-6 weeks, bleed the mice to check for reconstitution on the basis of GFP + and TCR coexpression.
? trouBlesHootInG step 8 Viral producer cell lines should be in early passages, and they should not be grown to confluency, as this will reduce the viral titer.
step 9
Ensuring the health of the bone marrow progenitors is crucial to the success of the protocol. To this end, ensure that cytokines and media are fresh. Cytokines should not be used if they are older than 2 weeks when kept at 4 °C, and DMEM should not be used for more than 4 weeks after it is supplemented with FCS.
step 12
It is also crucial to spin-transduce the plates containing bone marrow cells at 37 °C and to have them wrapped in plastic wrap to prevent gas exchange as much as possible.
antIcIpated results
This change to the procedure does not change the overall results of the protocol, as already extensively discussed in ref. 
